227 related articles for article (PubMed ID: 34830144)
1. Bone Formation Ability and Cell Viability Enhancement of MC3T3-E1 Cells by Ferrostatin-1 a Ferroptosis Inhibitor of Cancer Cells.
Valanezhad A; Odatsu T; Abe S; Watanabe I
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830144
[TBL] [Abstract][Full Text] [Related]
2. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic protection and mechanisms of ferrostatin-1 on hematopoietic acute radiation syndrome of mice.
Zhang X; Tian M; Li X; Zheng C; Wang A; Feng J; Hu X; Chang S; Zhang H
Int J Radiat Biol; 2021; 97(4):464-473. PubMed ID: 33464146
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis-inducing agents compromise in vitro human islet viability and function.
Bruni A; Pepper AR; Pawlick RL; Gala-Lopez B; Gamble AF; Kin T; Seeberger K; Korbutt GS; Bornstein SR; Linkermann A; Shapiro AMJ
Cell Death Dis; 2018 May; 9(6):595. PubMed ID: 29789532
[TBL] [Abstract][Full Text] [Related]
6. Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells.
Adedoyin O; Boddu R; Traylor A; Lever JM; Bolisetty S; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 May; 314(5):F702-F714. PubMed ID: 28515173
[TBL] [Abstract][Full Text] [Related]
7. Lipid Peroxidation, GSH Depletion, and
Sun L; Dong H; Zhang W; Wang N; Ni N; Bai X; Liu N
DNA Cell Biol; 2021 Feb; 40(2):172-183. PubMed ID: 33351681
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Re Promotes Osteoblast Differentiation in Mouse Osteoblast Precursor MC3T3-E1 Cells and a Zebrafish Model.
Kim HM; Kim DH; Han HJ; Park CM; Ganipisetti SR; Valan Arasu M; Kim YO; Park CG; Kim BY; Soung NK
Molecules; 2016 Dec; 22(1):. PubMed ID: 28036069
[TBL] [Abstract][Full Text] [Related]
9. Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes.
Li S; Zhou C; Zhu Y; Chao Z; Sheng Z; Zhang Y; Zhao Y
Int Immunopharmacol; 2021 Jan; 90():107179. PubMed ID: 33278745
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of formylpiperazine analogs of Ferrostatin-1 as novel improved ferroptosis inhibitors.
Ji HL; Zhang YF; Zhang NY; Wang KM; Meng N; Zhang J; Jiang CS
Bioorg Med Chem; 2024 May; 105():117716. PubMed ID: 38608329
[TBL] [Abstract][Full Text] [Related]
11. The dual-effects of LaCl₃ on the proliferation, osteogenic differentiation, and mineralization of MC3T3-E1 cells.
Liu D; Zhang J; Wang G; Liu X; Wang S; Yang M
Biol Trace Elem Res; 2012 Dec; 150(1-3):433-40. PubMed ID: 22886987
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the bone resorption supernatant from RAW264.7 osteoclast on the osteogenic activity of mouse MC3T3-E1 cell].
Chen LL; Wang K; Zhang J; Wu YM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jan; 47(1):32-7. PubMed ID: 22490219
[TBL] [Abstract][Full Text] [Related]
13. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis.
Liu P; Feng Y; Li H; Chen X; Wang G; Xu S; Li Y; Zhao L
Cell Mol Biol Lett; 2020; 25():10. PubMed ID: 32161620
[TBL] [Abstract][Full Text] [Related]
14. Ferrostatin-1 Alleviates White Matter Injury Via Decreasing Ferroptosis Following Spinal Cord Injury.
Ge H; Xue X; Xian J; Yuan L; Wang L; Zou Y; Zhong J; Jiang Z; Shi J; Chen T; Su H; Feng H; Hu S
Mol Neurobiol; 2022 Jan; 59(1):161-176. PubMed ID: 34635980
[TBL] [Abstract][Full Text] [Related]
15. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
[TBL] [Abstract][Full Text] [Related]
16. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
17. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
Wang W; Olson D; Cheng B; Guo X; Wang K
J Ethnopharmacol; 2012 Jun; 142(1):168-74. PubMed ID: 22543168
[TBL] [Abstract][Full Text] [Related]
18. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis.
Hu Z; Zhang H; Yi B; Yang S; Liu J; Hu J; Wang J; Cao K; Zhang W
Cell Death Dis; 2020 Jan; 11(1):73. PubMed ID: 31996668
[TBL] [Abstract][Full Text] [Related]
19. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2.
Zhang W; Wu Y; Shiozaki Y; Sugimoto Y; Takigawa T; Tanaka M; Matsukawa A; Ozaki T
DNA Cell Biol; 2018 Mar; 37(3):199-209. PubMed ID: 29359964
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha inhibits osteogenic differentiation of pre-osteoblasts by downregulation of EphB4 signaling via activated nuclear factor-kappaB signaling pathway.
Wang LM; Zhao N; Zhang J; Sun QF; Yang CZ; Yang PS
J Periodontal Res; 2018 Feb; 53(1):66-72. PubMed ID: 28857167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
